Despite the close structural similarity between the heptapeptide cores of the glycopeptide antibiotics teicoplanin and ristocetin, synthetically modified derivatives of their aglycons show significantly different antibacterial and antiviral properties. The teicoplanin aglycon derivatives with one exception proved to be potent antibacterials but they did not exhibit anti-influenza virus activity. In contrast, the aglycoristocetin derivatives generally showed high anti-influenza virus activity and possessed moderate antibacterial activity. A systematic structure-activity relationship study has been carried out on ristocetin and teicoplanin aglycon derivatives, to explore which structural differences are responsible for these markedly differen...
Copyright © 2012 Isaac Asusheyi Bello et al. This is an open access article distributed under the Cr...
The aim of experiment is to synthesize a new teicoplanin pseudoaglycon derivative through a maleimid...
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. ...
Despite the close structural similarity between the heptapeptide cores of the glycopeptide antibioti...
Six series of semisynthetic lipophilic glycopeptide antibiotic derivatives were evaluated for in vit...
In order to obtain new, cluster-forming antibiotic compounds, teicoplanin pseudoaglycone derivatives...
Introduction: The increased resistance of glycopeptide based antibiotics has become a serious proble...
OBJECTIVES: Some semi-synthetic derivatives of glycopeptide antibiotics have been shown to exert in ...
Influenza A and B viruses are a global threat to human health and increasing resistance to the exist...
Glycopeptide antibiotics are considered against the often fatal infection of gram positive bacteria...
We previously reported on the in vitro anti-influenza virus activity and structure-activity relation...
Glycopeptide antibiotics, such as vancomycin and teicoplanin, are used to treat life-threatening inf...
The protracted global COVID-19 pandemic urges the development of new drugs against the causative age...
The protracted global COVID-19 pandemic urges the development of new drugs against the causative age...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Copyright © 2012 Isaac Asusheyi Bello et al. This is an open access article distributed under the Cr...
The aim of experiment is to synthesize a new teicoplanin pseudoaglycon derivative through a maleimid...
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. ...
Despite the close structural similarity between the heptapeptide cores of the glycopeptide antibioti...
Six series of semisynthetic lipophilic glycopeptide antibiotic derivatives were evaluated for in vit...
In order to obtain new, cluster-forming antibiotic compounds, teicoplanin pseudoaglycone derivatives...
Introduction: The increased resistance of glycopeptide based antibiotics has become a serious proble...
OBJECTIVES: Some semi-synthetic derivatives of glycopeptide antibiotics have been shown to exert in ...
Influenza A and B viruses are a global threat to human health and increasing resistance to the exist...
Glycopeptide antibiotics are considered against the often fatal infection of gram positive bacteria...
We previously reported on the in vitro anti-influenza virus activity and structure-activity relation...
Glycopeptide antibiotics, such as vancomycin and teicoplanin, are used to treat life-threatening inf...
The protracted global COVID-19 pandemic urges the development of new drugs against the causative age...
The protracted global COVID-19 pandemic urges the development of new drugs against the causative age...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Copyright © 2012 Isaac Asusheyi Bello et al. This is an open access article distributed under the Cr...
The aim of experiment is to synthesize a new teicoplanin pseudoaglycon derivative through a maleimid...
Vancomycin and teicoplanin are still the only glycopeptide antibiotics available for use in humans. ...